Pediatrix Medical Group (MD) executive compensation, 2026 proxy

Mark S. Ordan, Chief Executive Officer, was paid $14.1M in 2025. The CEO-to-median-employee pay ratio was 91:1, on median employee pay of $155,070.

Filed
March 27, 2026
Annual meeting
May 7, 2026
Pay year
2025
Named executives
5
CEO total pay
$14.1M2025
CEO to median employee
91:1median $155,070
CEO pay in equity
60%$8.5M in awards
Prior say-on-pay support
93%of votes cast
CEO Stock Awards
$8,456,024Granted in 2025
CEO Non-Equity Incentive
$2,700,000Earned for 2025
Say-on-Pay Support
93%At 2025 annual meeting

How Ordan was paid

$14.1M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary7%Bonus14%Stock awards60%Non-equity incentive19%All other compensation0%

Named executive officers

ExecutiveTotal
Mark S. OrdanChief Executive Officer$14,140,217
Kasandra H. RossiExecutive Vice President, Chief Financial Officer & Treasurer$1,860,037
Mary Ann E. MooreExecutive Vice President, General Counsel, Chief Administrative Officer and Secretary$3,031,152
Don Gregory NeebExecutive Vice President, Chief Investment & Strategy Officer$5,317,268
James D. Swift, M.D.Former Chief Executive Officer$2,775,881

What changed and why

  • $14.1MMark S. Ordan received total compensation of $14,140,217 following his appointment as Chief Executive Officer in 2025.
  • $2MCEO compensation included a one-time cash retention award of $2,000,000 paid upon commencement of employment.
  • Long-term incentive awards consist of performance share awards and time-based restricted stock awards.
  • 93%The say-on-pay proposal received approximately 93% support at the 2025 annual meeting.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.